semaglutide and nonarteritic anterior ischemic optic neuropathy Risk of (NAION) in patients prescribed - Novo Nordisk A new study suggests patients

Surles T

Semaglutide is a prescription medication that belongs to a class of drugs known as GLP-1 receptor agonists

Setting realistic expectations prevents discouragement during the initial phase when progress may not yet be visible

In a 2021 clinical trial of over 900 adults, about 80% of people with obesity lost 5% of their body weight after taking phentermine for 6 months

A 2mg/mL concentration (5mg vial in 2.5mL BAC water) requires a 1mL injection for a 2mg dose, while a 4mg/mL concentration (10mg vial in 2.5mL) requires only 0.5mL for the same 2mg dose

Our team reviewed dozens of GLP1 patches and narrowed them down to the five most popular options on the market